CLINICAL_TRIALS
trial_result
· 2014-01-06
Clinical Trial Update: Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Summary
A Phase 2 clinical trial evaluating irradiated donor lymphocytes for metastatic renal cell carcinoma has terminated with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rutgers, The State University of New Jersey | Conditions: Kidney Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-01-06